| Dr James Vincent Prochazka, MD | |
|
9300 Valley Childrens Pl, Madera, CA 93638-8761 | |
| (559) 353-6257 | |
| (559) 353-5455 |
| Full Name | Dr James Vincent Prochazka |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Pediatric Cardiology |
| Location | 9300 Valley Childrens Pl, Madera, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083723852 | NPI | - | NPPES |
| C329992 | Other | CA | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0202X | Pediatrics - Pediatric Cardiology | C32992 (California) | Primary |
| Entity Name | Valley Childrens Specialty Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013968296 PECOS PAC ID: 9638072614 Enrollment ID: O20040128000542 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The pain of losing a body part is twofold, as the patients not only suffer from wound pain. Often they are also affected by so called phantom pain. Unlike bodily wounds which will eventually heal, phantom pain often lasts for years and sometimes a lifetime. "Phantom pain is very difficult to treat", says Professor Dr Thomas Weiss from the Friedrich-Schiller-University Jena.
Uniting Against Lung Cancer (Uniting) announces the "Caine Halter Hope Now Award for Lung Cancer Research."
Researchers look to understand the causes of amyotrophic lateral sclerosis (ALS), in the hope of finding new ways to treat the disease. A new study published online today (December 17th) in the Cell Press journal Neuron shows that a common gene mutation in ALS generates a deadly protein that may cause the damage in the brain that leads to ALS.
The financial contributions made some years ago by individuals and public administration bodies in the telemarathon solidarity events on the Basque Public Broadcasting Corporation (EiTB) and subsequently channelled through the Basque Foundation for Health Innovation and Research (BIOEF), has resulted in undertaking successful innovative research at the Cruces Hospital near Bilbao in the Basque province of Bizkaia, describing a new syndrome of limited family intellectual disability.
› Verified 4 days ago
| Entity Name | Valley Childrens Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437555265 PECOS PAC ID: 9032439336 Enrollment ID: O20150528001593 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The pain of losing a body part is twofold, as the patients not only suffer from wound pain. Often they are also affected by so called phantom pain. Unlike bodily wounds which will eventually heal, phantom pain often lasts for years and sometimes a lifetime. "Phantom pain is very difficult to treat", says Professor Dr Thomas Weiss from the Friedrich-Schiller-University Jena.
Uniting Against Lung Cancer (Uniting) announces the "Caine Halter Hope Now Award for Lung Cancer Research."
Researchers look to understand the causes of amyotrophic lateral sclerosis (ALS), in the hope of finding new ways to treat the disease. A new study published online today (December 17th) in the Cell Press journal Neuron shows that a common gene mutation in ALS generates a deadly protein that may cause the damage in the brain that leads to ALS.
The financial contributions made some years ago by individuals and public administration bodies in the telemarathon solidarity events on the Basque Public Broadcasting Corporation (EiTB) and subsequently channelled through the Basque Foundation for Health Innovation and Research (BIOEF), has resulted in undertaking successful innovative research at the Cruces Hospital near Bilbao in the Basque province of Bizkaia, describing a new syndrome of limited family intellectual disability.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Vincent Prochazka, MD 3333 W Chennault Ave, Fresno, CA 93711-0218 Ph: (559) 353-6257 | Dr James Vincent Prochazka, MD 9300 Valley Childrens Pl, Madera, CA 93638-8761 Ph: (559) 353-6257 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the "Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus" trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.
The pain of losing a body part is twofold, as the patients not only suffer from wound pain. Often they are also affected by so called phantom pain. Unlike bodily wounds which will eventually heal, phantom pain often lasts for years and sometimes a lifetime. "Phantom pain is very difficult to treat", says Professor Dr Thomas Weiss from the Friedrich-Schiller-University Jena.
Uniting Against Lung Cancer (Uniting) announces the "Caine Halter Hope Now Award for Lung Cancer Research."
Researchers look to understand the causes of amyotrophic lateral sclerosis (ALS), in the hope of finding new ways to treat the disease. A new study published online today (December 17th) in the Cell Press journal Neuron shows that a common gene mutation in ALS generates a deadly protein that may cause the damage in the brain that leads to ALS.
The financial contributions made some years ago by individuals and public administration bodies in the telemarathon solidarity events on the Basque Public Broadcasting Corporation (EiTB) and subsequently channelled through the Basque Foundation for Health Innovation and Research (BIOEF), has resulted in undertaking successful innovative research at the Cruces Hospital near Bilbao in the Basque province of Bizkaia, describing a new syndrome of limited family intellectual disability.
› Verified 4 days ago
Dr. Meera Ramayya, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9300 Valley Childrens Pl, Mb23, Madera, CA 93636 Phone: 559-353-6600 Fax: 559-353-6612 | |
Dr. Sudhakar Reddivalam, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9300 Valley Childrens Pl, Madera, CA 93638 Phone: 559-353-5550 Fax: 559-353-5587 | |
Dr. Whitney Lyn Kalin, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9300 Valley Childrens Pl, Madera, CA 93636 Phone: 559-353-5700 Fax: 559-353-5708 | |
John Sanchez, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 9300 Valley Childrens Pl, Madera, CA 93638 Phone: 559-353-5068 Fax: 559-353-5426 | |
Dr. Jeffrey Thomas Pietz, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9300 Valley Childrens Pl # Se21, Madera, CA 93636 Phone: 559-353-8769 | |
Saul Jacob, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 9300 Valley Childrens Pl # Gw12, Madera, CA 93636 Phone: 559-353-5068 Fax: 559-353-5426 | |
Keenia Tappin, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 9300 Valley Childrens Pl, Madera, CA 93636 Phone: 559-353-5174 |